News

Date  
Sep, 22nd 2017MedNous, Genenta raises €7 million in Series B round
Sep 13th, 2017LaBiotech, Italian Biotech Closes €7M Series B for Stem Cells to Treat Cancer
Sep 13th, 2017BioCentury, Genenta Raises €7M In Series B
Sep 13th, 2017Endpoints News, Genenta adds $8M for gene therapy R&D
Jan 29th, 2017MedNous, Carlo Russo becomes CMO at Genenta Science
Jan 19th, 2017FierceBiotech, Ex-GSK rare disease head moves to Genenta
Jan 19th, 2017Endpoints, GSK R&D vet Russo jumps to Genenta, takes a lead role in developing a new gene therapy
Sep 26th, 2016BioCentury, Genenta Science, Amgen, Ospedale San Raffaele deal
Sep 22nd, 2016 FierceBiotech, Genenta Science and Ospedale San Raffaele landed a deal with Amgen
Sep 20th, 2016Labiotech, Italian Gene Therapy Biotech aims high by collaborating with US giant Amgen
Sep 18th, 2016MedNous, Amgen to work with Italian scientists on new gene therapy
Sep 16th, 2016 Endpoints, Protocols: Amgen partners with Genenta, San Raffaele on an anti-tumor drug
Mar 24th 2016FierceBiotech, Manufacturing Agreement
Mar 9th, 2015 BioCentury, Genenta Science financial update
Mar 5th, 2015FierceBiotech, Italy’s Genenta Science raises $11M for gene therapy program at TIGET
Jan 27th, 2015LaBiotech, Genenta Science raised €6.2M
Jan 23rd, 2015FierceBiotech, Genenta Science raises €6.2M in first tranche of series A funding
Jan 23rd, 2015BioCentury Extra, Gene therapy newco Genenta raises EUR 6.2M toward series A
Jan 23rd, 2015BioWorld, Italian gene therapy start-up Genenta banks 7$M in series A round